Mesoblast (MESO) EBT (QoQ) (2014 - 2023)
Mesoblast (MESO) EBT (QoQ) (2014 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Mesoblast | 2.08 Bn | 1.95 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -17.77% |
| Mar 31, 2023 | 24.07% |
| Dec 31, 2022 | -44.97% |
| Sep 30, 2022 | 21.24% |
| Jun 30, 2022 | -0.75% |
| Mar 31, 2022 | 17.98% |
| Dec 31, 2021 | -14.61% |
| Sep 30, 2021 | -2.63% |
| Jun 30, 2021 | 16.86% |
| Mar 31, 2021 | -3.88% |
| Dec 31, 2020 | -1.36% |
| Sep 30, 2020 | 29.53% |
| Jun 30, 2020 | -108.31% |
| Mar 31, 2020 | 35.88% |
| Dec 31, 2019 | -262.10% |
| Sep 30, 2019 | 68.97% |
| Jun 30, 2019 | 12.04% |
| Mar 31, 2019 | 1.07% |
| Dec 31, 2018 | -35.92% |
| Sep 30, 2018 | 7.53% |